MS-PLMorgan Stanley
The schedule
- Thu15Oct
Expected finalization of U.S. capital requirements for large banks, determining the regulatory capital buffers supporting Morgan Stanley's preferred shares.
- Mon2Nov
Third-quarter results will highlight Morgan Stanley's operational stability, fixed-income coverage ratios, and wealth management fee generation.
- Tue9Feb
Full-year financial results outlining annual capital return frameworks, impacting the perceived safety and valuation of the firm's preferred tranches.
- Tue4May
First-quarter earnings will gauge Morgan Stanley's fundamental momentum and ability to protect margins in the prevailing macroeconomic regime.
- Mon2Aug
Past
- Wed16Sep
The Federal Reserve's September decision will provide essential guidance on the trajectory of benchmark rates, heavily influencing preferred equity yields.
- Mon3Aug
Actual outcome: Bear
Morgan Stanley reported Q2 EPS of $3.44, exactly matching consensus estimates. Despite meeting headline expectations, the stock fell below the $19.50 bear floor as the report lacked the necessary upside surprises in wealth management asset flows and investment banking recovery to drive momentum. The absence of a strong forward catalyst ultimately pressured the shares downward.
Morgan Stanley reported Q2 EPS of $3.44, exactly matching consensus estimates. Despite meeting headline expectations, the stock fell below the $19.50 bear floor as the report lacked the necessary upside surprises in wealth management asset flows and investment banking recovery to drive momentum. The absence of a strong forward catalyst ultimately pressured the shares downward.
- Sat27Jun
Actual outcome: Bear · $19.35 at outcome
Morgan Stanley met EPS estimates exactly at $3.44, but the release of the Fed's CCAR stress test results and the bank's capital return plan pressured the preferred shares. The results likely signaled a tighter capital buffer, negatively impacting the perceived safety profile of MS-PL as a preferred yield instrument and driving the stock down toward the bear floor.
The Federal Reserve's CCAR stress test results will confirm Morgan Stanley's capital buffer, directly impacting the safety profile of MS-PL as a preferred yield instrument. Resolves at a target of $20.26 or a fallback of $19.32.
